Skip to content
Home/Companies/Biotech/NeoVacs
NE

NeoVacs

Biotech·France·Active

NeoVacs is a biotech company, headquartered in France.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns NeoVacs?

NeoVacs is currently owned by Odyssée Venture through Odyssee Venture Funds (1999 vintage).

Hand-verified · updated 2026-05-21

Odyssée Venture
Investor
Odyssée Venture
Odyssee Venture Funds · 1999 · VC

Key facts

HQFrance
SectorBiotech
StatusActive

More from Odyssee Venture Funds

Other portfolio companies in the same fund.

Ausy
Exited 2017
IT ServicesFrance
to
DLSoftware
Exited 2017
SoftwareFrance
to
Emme
Exited 2007
TMTFrance
to
EWave
Exited 2000
E-commerceFrance
to
Focus
Exited 2015
GamingFrance
HFCompany
Active
TelecomFrance

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings